Lupin intros generic Depakote ER

Lupin is offering divalproex sodium extended-release tablets in dosage strengths of 250 mg and 500 mg,

The product is the generic of AbbVie’s Depakote ER tablets.

It is indicated for the acute treatment of manic or mixed episodes associated with bipolar disorder, with or without psychotic features; monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures; and prophylaxis of migraine headaches.

Lupin's drug will be manufactured at its Nagpur facility in India.

Divalproex sodium ER tablets had a market value of approximately $130 million, according to IQVIA July 2020 data.